Heng Aw Appointed to Lead CrowdPharm Asia Pacific

Share

CrowdPharm Expands into Asia Pacific With Singapore Office
Aw to Lead Business Development and Talent Recruitment

KANSAS CITY, MO—April 26, 2023—CrowdPharm, an independent full-service agency with healthcare’s largest network of global talent, announced today a strategic alliance that expands the agency’s global presence in the Asia-Pacific region. The alliance with WeTheBrand allows both companies to continue their successful business relationship under the new brand identity CrowdPharm Asia Pacific. They will work in concert to increase marketing and advertising value for their customers and stakeholders in the pharmaceutical and healthcare industry.

CrowdPharm also announced today the appointment of Heng Aw as Regional Director for CrowdPharm Asia Pacific. Based in Singapore, Aw will continue working with the agency’s Asia-Pacific resources, oversee operations, and manage the agency’s work through WeTheBrand. He will also drive business development and talent recruitment to continue to grow the team.

Aw has extensive experience with branding, marketing, advertising and agency business. He has established a successful track record for managing and growing brands and companies, and hands-on experience sitting at both sides of the client-agency table.

Aw has gained deep insights into Asian consumers at Survey Research Singapore (now Nielsen Singapore), where he headed the Omnibus and Syndicated Studies Department conducting big-scale annual industry tracking studies for categories like automobiles, electrical appliances, skincare, haircare, tourism, beer, and spirits. This was augmented by his time as General Manager at a local independent full-service advertising agency. He also co-founded an interactive multimedia agency during the dotcom days working with global brands like Fuji Films, Hyundai, Red Bull, and Toys-R-Us.

As head of the marketing team in Asia Dairies (now F&N Foods), Singapore’s largest dairy company, he managed marketing of their market-leading brands like Magnolia, Meadow Gold, and Fruit Tree.

Aw’s experience is not restricted to the Singapore market. Since 1996, he has worked with companies and communications agencies in the Asia-Pacific region, including the consumer products division of Novartis, and as the Regional Executive Director of Worldwide Partners, a global network of independent marketing agencies with members in 60+ countries. He recruited and worked with healthcare agencies in Asia-Pacific markets as members of the Healthcare Sub-Network. He was also the lead for the Asia-Pacific business expansion of an ad-tech company, providing location audience measurement services by managing relationships with and driving revenue from advertisers and media agencies.

Aw is a member of the Singapore Institute of Directors. He now puts his wealth of varied experience and knowledge to advising startups and adtech/martech companies to achieve their business growth goals and exit strategies. He graduated with a BA (Hons) in Accountancy, after which he served his CPA training in various accountancy firms in London, UK; he also earned his MBA in International Business from BAYES Business School, City University of London.

About CrowdPharm
CrowdPharm is an independent full-service agency led by industry veterans and fueled by the largest network of global talent anywhere. Innovative technology enables the agency to deliver an abundance of original strategic and creative solutions and provide a flexible force of talent with experience that spans startups, orphan products, blockbusters, and primary care. With 6,800+ members across 120+ countries, the agency is ready to develop compelling brand communications in healthcare, medical, and pharmaceutical marketing for pharmaceutical and biopharma companies. Visit crowdpharm.com.

For more information, contact:
Lori Goodale
VP, Director of Marketing and Corporate Communications
518.366.7230
lorigoodale@crowdpharm.com

More posts
CrowdPharm Announces Appointment and Promotion
Read more >
Ray Colon Named One of the 2024 PM360 ELITE 100
Read more >
New Artist-Protecting Technology Helps Fight Against Copyright Violation
Read more >
See more